Kang Choon Lee
10Patents
2h-index
19Co-inventors
51Inventor score
Filing activity: Aug 15, 2000 → Apr 6, 2021
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6506730B1 | Nasal transmucosal delivery of peptide conjugated with biocompatible polymers | Human Necessities | 40 | Expired |
| US8420598B2 | Mono modified exendin with polyethylene glycol or its derivatives and uses thereof | Human Necessities | 8 | Active |
| US9901620B2 | Trail receptor agonists for treatment of fibrotic disease | Chemistry; Metallurgy | 2 | Active |
| US9321825B2 | N-terminal modified PEG-TRAIL | Physics | 1 | Active |
| US11299528B2 | Long acting TRAIL receptor agonists for treatment of autoimmune diseases | Chemistry; Metallurgy | 0 | Active |
| US8466103B2 | Exendin polypeptide linked to biotin, method for the preparation thereof and pharmaceutical composition comprising the same | Human Necessities | 0 | Active |
| US7662915B2 | Peptides having protected amines of untargeted sites, methods for production thereof and of specifically conjugated PEG peptides using the same | Chemistry; Metallurgy | 0 | Expired |
| US11767353B2 | Trail compositions with reduced immunogenicity | Chemistry; Metallurgy | 0 | Active |
| US10046059B2 | Methods of administering an N-terminal modified PEG-TRAIL | Physics | 0 | Active |
| US12338270B2 | Pharmaceutical composition comprising polypeptide | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.